Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Danco Laboratories LLC genitourinary news

    Danco Laboratories LLC, New York, N.Y. Business: Genitourinary Oklahoma Gov. Mary Fallin signed into law a bill that prohibits off-label use of Danco's Mifeprex mifepristone (RU-486), which is indicated for the medical …

    Published on 4/28/2014
  • Eli Lilly, J&J, Merck, Roche cancer, autoimmune news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer,…

    Published on 4/28/2014
  • Endo, Hisamitsu, Teikoku Seiyaku, TWi Pharmaceuticals neurology news

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Teikoku Seiyaku Co. Ltd., Higashikagawa, Japan TWi Pharmaceuticals Holding Inc. (GreTai:4180), …

    Published on 4/28/2014
  • Endofotonics, National University of Singapore diagnostic news

    Endofotonics Pte. Ltd., Singapore National University of Singapore, Singapore Business: Diagnostic The university spun off newco Endofotonics, which is developing its IMDX molecular diagnostic system for instant cancer …

    Published on 4/28/2014
  • Genetic Technologies, ImmunAid Ltd. other news

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia ImmunAid Ltd., Fitzroy, Australia Business: Other At an extraordinary general meeting, Genetic shareholders approved a deal in which founder Mervyn …

    Published on 4/28/2014
  • Teva autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune The U.S. Supreme Court denied a motion from Teva to stay an appeals court ruling that will end exclusivity for the biotech's …

    Published on 4/28/2014
  • XenoPort autoimmune, neurology news

    XenoPort Inc. (NASDAQ:XNPT), Santa Clara, Calif. Business: Autoimmune, Neurology XenoPort investor Clinton Relational Opportunity Master Fund L.P. has nominated a slate of three directors to the biotech's board to …

    Published on 4/28/2014
  • Zogenix neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Massachusetts Gov. Deval Patrick said doctors are now required to check a patient's controlled-substance history through a statewide prescription …

    Published on 4/28/2014
  • Applikon Biotechnology biomanufacturing news

    Applikon Biotechnology B.V., Delft, the Netherlands Business: Biomanufacturing Applikon launched a new production facility in Guangzhou, China. The company said the facility will provide a range of bioreactor systems, …

    Published on 3/24/2014
  • Arrowhead, Calando drug delivery, cancer news

    Arrowhead Research Corp. (NASDAQ:ARWR), Pasadena, Calif. Calando Pharmaceuticals Inc., Pasadena, Calif. Business: Drug delivery, Cancer Arrowhead said that subsidiary Calando ceased day-to-day operations after it …

    Published on 3/24/2014
  • Chiome antibodies news

    Chiome Bioscience Inc. (Tokyo:4583), Tokyo, Japan Business: Antibodies Chiome said it constructed and verified a DT40 cell line for the human ADLib (Autonomously Diversifying Library) system to generate mAbs in vitro. …

    Published on 3/24/2014
  • Galena Biopharma, U.S. Securities and Exchange Commission (SEC) finance news

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. U.S. Securities and Exchange Commission (SEC), Washington, D.C. Business: Finance Galena disclosed in its 10-K filed on March 17 that the SEC began investigating …

    Published on 3/24/2014
  • Gilead, Idenix infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Cambridge, Mass Business: Infectious Democratic members of the U.S. House of Representatives Energy and Commerce …

    Published on 3/24/2014
  • Japan BCG, Astellas, Dainippon Sumitomo, Eisai, Merck KGaA, Aeras, Drugs for Neglected Diseases initiative (DNDi), Liverpool School of Tropical Medicine (LSTM), National Institute of Biomedical ...

    Japan BCG Laboratory Ltd., Tokyo, Japan Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Merck KGaA (Xetra:MRK), …

    Published on 3/24/2014
  • Maravai Life Sciences diagnostic news

    Maravai Life Sciences Inc., San Diego, Calif. Business: Diagnostic Private equity firm GTCR launched newco Maravai along with two former executives from molecular diagnostics company Gen-Probe Inc. GTCR will provide up …

    Published on 3/24/2014
  • Actelion, Asahi Kasei Pharma cardiovascular news

    Actelion Ltd. (SIX:ATLN), Allschwil, Switzerland Asahi Kasei Pharma Corp., Tokyo, Japan Business: Cardiovascular The California Supreme Court denied a petition filed by Actelion to review a lower court decision in Asahi…

    Published on 3/17/2014
  • Ambry Genetics, Myriad Genetics diagnostic news

    Ambry Genetics Corp., Aliso Viejo, Calif. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic The U.S. District Court for the District of Utah denied Myriad's motion for preliminary injunction …

    Published on 3/17/2014
  • Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers, Eli Lilly, GlaxoSmithKline, J&J, Merck, Merck KGaA, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, Innovative Medicines Initiative ( ...

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Bayer AG (Xetra:BAYN), Leverkusen, Germany Boehringer Ingelheim GmbH, Ingelheim, Germany Bristol-Myers Squibb Co. (NYSE:…

    Published on 3/17/2014
  • Anika, Sanofi neurology news

    Anika Therapeutics Inc. (NASDAQ:ANIK), Bedford, Mass. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Neurology On March 10, the U.S. District Court for the District of Massachusetts granted a joint motion …

    Published on 3/17/2014
  • AstraZeneca, Korea Health Industry Development Institute (KHIDI) cancer news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Korea Health Industry Development Institute (KHIDI), Gangoemyeon, South Korea Business: Cancer AstraZeneca and KHIDI signed a memorandum of understanding to establish an…

    Published on 3/17/2014
  • AstraZeneca, Manchester Science Parks (MSP) pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Manchester Science Parks (MSP), Manchester, U.K. Business: Pharmaceuticals AstraZeneca will sell its facility in Alderley Park, U.K., to MSP, a public-private science …

    Published on 3/17/2014
  • Bayer hematology news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Hematology Bayer said it will invest more than 500 million ($694.8 million) to establish additional manufacturing capacities of its recombinant Factor VIII (rFVIII) …

    Published on 3/17/2014
  • Bicoll GmbH, Charite - Universitaetsmedizin Berlin, German Federal Ministry of Education and Research neurology news

    Bicoll GmbH, Munich, Germany Charite - Universitaetsmedizin Berlin, Berlin, Germany German Federal Ministry of Education and Research, Berlin, Germany Business: Neurology Bicoll and Charite's Horst-Goertz-Endowment …

    Published on 3/17/2014
  • Bio-Matrix Scientific gene/cell therapy, hematology, cancer news

    Bio-Matrix Scientific Group Inc. (OTCQB:BMSN; Pink:BMSN), La Mesa, Calif. Business: Gene/Cell therapy, Hematology, Cancer Bio-Matrix said that all shareholders on record as of March 18 will receive one share in …

    Published on 3/17/2014
  • Corgenix Medical Corp. diagnostic news

    Corgenix Medical Corp. (OTCBB:CONX), Broomfield, Colo. Business: Diagnostic Corgenix's board said it is exploring strategic alternatives. Inverness Advisors is advising Corgenix, which is not disclosing further details …

    Published on 3/17/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993